healthcare

healthcare Articles

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment of seizures associated with Dravet syndrome.
PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.
Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA interference therapeutics for a broad range of diseases.
Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.
Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs as well as conducting layoffs.
Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.
Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model of Parkinson’s disease.
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer.
Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of...
Walgreens Boots Alliance released disappointing fiscal second-quarter financial results before the markets opened on Tuesday
Health care costs in the United States are generally measured as the highest in the world. Last year, many Americans could not afford their health care costs.
Tilray shares dipped on Monday despite its announcement that it would be branching out and supporting two new clinical studies.
Walgreens Boots Alliance is scheduled to release its fiscal second-quarter financial results before the markets open on Tuesday.